Your browser doesn't support javascript.
loading
Use of a gene expression signature to identify trimetazidine for repurposing to treat bipolar depression.
Bortolasci, Chiara C; Kidnapillai, Srisaiyini; Spolding, Briana; Truong, Trang T T; Connor, Timothy; Swinton, Courtney; Panizzutti, Bruna; Liu, Zoe S J; Sanigorski, Andrew; Dean, Olivia M; Crowley, Tamsyn; Richardson, Mark; Bozaoglu, Kiymet; Vlahos, Katerina; Cowdery, Stephanie; Watmuff, Brad; Steyn, Stephan F; Wolmarans, De Wet; Engelbrecht, Barend J; Perry, Christina; Drummond, Katherine; Pang, Terence; Jamain, Stéphane; Gray, Laura; McGee, Sean L; Harvey, Brian H; Kim, Jee Hyun; Leboyer, Marion; Berk, Michael; Walder, Ken.
Afiliação
  • Bortolasci CC; IMPACT, The Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Deakin University, Geelong, Australia.
  • Kidnapillai S; IMPACT, The Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Deakin University, Geelong, Australia.
  • Spolding B; IMPACT, The Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Deakin University, Geelong, Australia.
  • Truong TTT; IMPACT, The Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Deakin University, Geelong, Australia.
  • Connor T; IMPACT, The Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Deakin University, Geelong, Australia.
  • Swinton C; IMPACT, The Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Deakin University, Geelong, Australia.
  • Panizzutti B; IMPACT, The Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Deakin University, Geelong, Australia.
  • Liu ZSJ; IMPACT, The Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Deakin University, Geelong, Australia.
  • Sanigorski A; IMPACT, The Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Deakin University, Geelong, Australia.
  • Dean OM; IMPACT, The Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Deakin University, Geelong, Australia.
  • Crowley T; The Florey Institute of Neuroscience and Mental Health, Parkville, Australia.
  • Richardson M; IMPACT, The Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Deakin University, Geelong, Australia.
  • Bozaoglu K; Bioinformatics Core Research Facility (BCRF), Deakin University, Geelong, Australia.
  • Vlahos K; Bioinformatics Core Research Facility (BCRF), Deakin University, Geelong, Australia.
  • Cowdery S; Murdoch Children's Research Institute, Parkville, Victoria, Australia.
  • Watmuff B; Department of Paediatrics, University of Melbourne, Parkville, Victoria, Australia.
  • Steyn SF; Murdoch Children's Research Institute, Parkville, Victoria, Australia.
  • Wolmarans W; IMPACT, The Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Deakin University, Geelong, Australia.
  • Engelbrecht BJ; IMPACT, The Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Deakin University, Geelong, Australia.
  • Perry C; Centre of Excellence for Pharmaceutical Sciences, Faculty of Health Sciences, North-West University, Potchefstroom, South Africa.
  • Drummond K; Centre of Excellence for Pharmaceutical Sciences, Faculty of Health Sciences, North-West University, Potchefstroom, South Africa.
  • Pang T; Centre of Excellence for Pharmaceutical Sciences, Faculty of Health Sciences, North-West University, Potchefstroom, South Africa.
  • Jamain S; The Florey Institute of Neuroscience and Mental Health, Parkville, Australia.
  • Gray L; The Florey Institute of Neuroscience and Mental Health, Parkville, Australia.
  • McGee SL; The Florey Institute of Neuroscience and Mental Health, Parkville, Australia.
  • Harvey BH; Univ Paris Est Créteil, INSERM, IMRB, Translational Neuropsychiatry, AP-HP, DMU IMPACT, FHU ADAPT, Fondation FondaMental, Créteil, France.
  • Kim JH; IMPACT, The Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Deakin University, Geelong, Australia.
  • Leboyer M; The Florey Institute of Neuroscience and Mental Health, Parkville, Australia.
  • Berk M; IMPACT, The Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Deakin University, Geelong, Australia.
  • Walder K; Centre of Excellence for Pharmaceutical Sciences, Faculty of Health Sciences, North-West University, Potchefstroom, South Africa.
Bipolar Disord ; 25(8): 661-670, 2023 12.
Article em En | MEDLINE | ID: mdl-36890661
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Trimetazidina / Transtorno Bipolar Limite: Animals / Humans Idioma: En Revista: Bipolar Disord Assunto da revista: PSIQUIATRIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Austrália
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Trimetazidina / Transtorno Bipolar Limite: Animals / Humans Idioma: En Revista: Bipolar Disord Assunto da revista: PSIQUIATRIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Austrália